In this study, we demonstrated for the first time that knocking down MARK4 in the STZ-induced DCM model improved lipid metabolism in mice, and high-throughput RNA-seq analysis was used to reveal the mechanism by which inhibition of MARK4 improves lipid metabolism by downregulating the expression of ACSL4. The gene discussed is MARK4; the disease is familial dilated cardiomyopathy.